Laura Chambers
@LAURAJMOULTON
Followers
467
Following
1K
Media
13
Statuses
112
Gynecologic Oncologist @OSUCCC_James | Trained at @CleObGynTracks @CleClinicMD | Interests: #ovariancancer #microbiome #hipec | Jack & Tuna's Mom
Columbus, OH
Joined July 2017
RT @cellhostmicrobe: From poo to promise: Fecal microbiota transplants support immunotherapy resensitization in solid tumors.@LAURAJMOULTON….
0
17
0
RT @CaseCos: Had a great time the other evening with my incredible partnersat @OSUCCC_James - @FBackesMD and @LAURAJMOULTON discussing the….
0
1
0
RT @FBackesMD: Excited to have many clinical trial opportunities for our patients and proud to be leading accrual for GOG foundation trials….
0
1
0
Excited to share our work about impact of antibiotics and PPI on endometrial.cancer patients @dspakowicz @omalleygynonc @OSUCCC_James.
Impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert
1
3
7
RT @IJGConline: #Editorial The inclusion of patient perspectives & timely management of toxicity in these guidelines should be applauded 👏….
0
5
0
RT @gynoncjnls: Type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer….
0
5
0
RT @mollyymorton: Thanks @gynoncjnls for helping us share our work! @LAURAJMOULTON . Prevalence of type 2 diabetes diagnoses in the periope….
0
3
0
RT @mollyymorton: Thank you to @greenjrnl, @LAURAJMOULTON for supporting this project - clinical trials improve outcomes for our patients!….
pubmed.ncbi.nlm.nih.gov
In this retrospective cohort of patients with platinum-resistant ovarian cancer, clinical trial participation was associated with improved overall survival compared with standard of care therapies....
0
3
0
RT @mollyymorton: A labor of love (and physiology) with @LAURAJMOULTON @OSUCCC_James .Malnutrition, sarcopenia, and cancer cachexia in gyne….
0
5
0
Proud of this important work by @MollyMorton17 @OSUCCC_James . “More than a song and dance”: Exploration of patient perspectives and .
0
4
10
RT @IJGConline: The modified 5-item frailty index is a predictor of post-operative complications in #VulvarCancer @LAURAJMOULTON @kbixelMD….
0
6
0
Excellent opening session presentation by @osugynonc fellow @MollyMorton17 on improved OS with clinical trial participation in platinum resistant OC @SGO_org @CleObGynTracks
0
3
22
RT @omalleygynonc: AddThis | Home .Now part of NCCN guidelines for PROC. Earlier opportunity to gain access for pat….
0
4
0
Dr O'Malley @omalleygynonc discussing the exciting GOG/NRG portfolio on ovarian cancer clinical trials @NRGonc @OSUCCC_James
0
0
11
My amazing partner @kbixelMD giving updates on ROCC trial @leitaomd @OSUCCC_James @osugynonc @NRGonc @omalleygynonc
0
2
19
Join me in attending The GOG Foundation, Inc. Dinner Meeting on Thursday, January 26th from 6:30 pm – 9:30 pm ET. For more information on this event for participating sites, go to . #clinicaltrials #GynecologicOncology #GOGPartners #GOGF.@GOG .@NRGonc
0
0
3
RT @CR_AACR: An intact #microbiome functions as a tumor suppressor in #OvarianCancer, and antibiotics perturb gut microbiota to promote tum….
0
5
0
Thrilled to share our work supporting that disruption of the #gutmicrobiome impacts platinum chemotherapy response in #ovariancancer just published in @CR_AACR. Such an important, collaborative effort @oreizes @ChadMichenerMD @RobertoVargasMD @CCLRI.
Advanced release of our manuscript “Disruption of the gut microbiota … is now online. Great collaboration with @ChadMichenerMD @LAURAJMOULTON @JustinLathia @claesengroup @RobertoVargasMD and many more @CCLRI @ClevelandClinic @caseccc.
1
3
14
Chambers-Spakowicz @dspakowicz labs seek a motivated postdoc to join a team studying the microbiome and chemo/IO treatment responses in gynecologic cancers at the @OhioStatePIIO and @OSUCCC_James! @osugynonc
0
2
5